TNF and lung carcinoma: Pro-inflammatory cytokines, such as IL-6 and TNF-α, are significantly elevated in lung cancer patients and contribute to endothelial dysfunction, plaque instability, and increased coagulation, all of which heighten cardiovascular risk (27, 28).